in the recurrent setting before bevacizumab | 8 | temporal |
for 18 months | 5 | temporal |
in size | 4 | other |
tumor → be → stable | 66 |
negative | neutral | positive |
0.115 | 0.562 | 0.323 |
Raw frequency | 66 |
Normalized frequency | 0.501 |
Modifier score | 0.900 |
Perplexity | 241.632 |